151 Nuclear Cardiology providers practice across all 50 states and Washington DC, and 60% received drug or device company payments in 2025. New Jersey has the most at 40. Listings are drawn from federal public records and are not endorsements.
Industry payment share ranges from 80% in New Jersey to 58% in New York, among states with 25 or more providers.
| State | Providers | Received payments |
|---|---|---|
| Nuclear Cardiology in New Jersey | 40 | 80% |
| Nuclear Cardiology in New York | 26 | 58% |
| Nuclear Cardiology in Pennsylvania | 16 | not reported |
| Nuclear Cardiology in California | 10 | not reported |
| Nuclear Cardiology in Texas | 10 | not reported |
| Nuclear Cardiology in Massachusetts | 8 | not reported |
| Nuclear Cardiology in Connecticut | 8 | not reported |
| Nuclear Cardiology in Florida | 6 | not reported |
| Nuclear Cardiology in Missouri | 6 | not reported |
| Nuclear Cardiology in North Carolina | 4 | not reported |
| Nuclear Cardiology in Georgia | 4 | not reported |
| Nuclear Cardiology in Virginia | 4 | not reported |
| Nuclear Cardiology in Tennessee | 3 | not reported |
| Nuclear Cardiology in Colorado | 3 | not reported |
| Nuclear Cardiology in Arizona | 3 | not reported |
There are 151 Nuclear Cardiology providers with active NPI records across all 50 states and Washington DC, according to federal NPPES data refreshed monthly. New Jersey has the most at 40.
90 of 151 Nuclear Cardiology providers nationally (60%) received at least one payment from a drug or device company in 2025, according to the federal Open Payments program. The share is highest in New Jersey at 80% and lowest in New York at 58%.
Provider counts come from the federal NPPES registry and CMS Doctors and Clinicians files. Payment figures come from the CMS Open Payments program for calendar year 2025. The directory refreshes monthly.
All specialties Ask Zach for help choosing